2023
DOI: 10.1016/j.gce.2022.07.004
|View full text |Cite
|
Sign up to set email alerts
|

Type I photosensitizer based on AIE chromophore tricyano-methylene-pyridine for photodynamic therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 54 publications
0
0
0
Order By: Relevance
“…As one of the most advanced PSs, aggregation-induced emission photosensitizers (AIE PSs) have received great attention due to their inherent advantages of high efficiency, good photostability, and excellent biocompatibility [28][29][30][31][32]. Precise molecular design by tuning the π-conjugation and electron donor-acceptor (D-A) moiety allowed AIE luminogens (AIEgens) to possess both Type I and Type II ROS generation abilities [33][34][35]. And the aggregation-induced intersystem crossing (AI-ISC) mechanism [36,37] has made AIE PSs more efficient in ROS generation in their aggregate state, which is pivotal for photodynamic-based masks.…”
Section: Introductionmentioning
confidence: 99%
“…As one of the most advanced PSs, aggregation-induced emission photosensitizers (AIE PSs) have received great attention due to their inherent advantages of high efficiency, good photostability, and excellent biocompatibility [28][29][30][31][32]. Precise molecular design by tuning the π-conjugation and electron donor-acceptor (D-A) moiety allowed AIE luminogens (AIEgens) to possess both Type I and Type II ROS generation abilities [33][34][35]. And the aggregation-induced intersystem crossing (AI-ISC) mechanism [36,37] has made AIE PSs more efficient in ROS generation in their aggregate state, which is pivotal for photodynamic-based masks.…”
Section: Introductionmentioning
confidence: 99%